Immune checkpoint inhibitors for urothelial carcinoma

Urothelial carcinoma (UC), originating in the bladder or upper urinary tract, is the most common histological type of cancer. Currently, platinum-based cytotoxic chemotherapy is the standard treatment for metastatic UC (mUC) and the preferred treatment option in the perioperative (neoadjuvant and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Suk, Seo, Ho Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121021/
https://www.ncbi.nlm.nih.gov/pubmed/30182073
http://dx.doi.org/10.4111/icu.2018.59.5.285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121021/
https://www.ncbi.nlm.nih.gov/pubmed/30182073
http://dx.doi.org/10.4111/icu.2018.59.5.285

Ejemplares similares